-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
ADC Therapeutics SA quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2024.
- ADC Therapeutics SA Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$30.7M, a 63.9% increase year-over-year.
- ADC Therapeutics SA Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$158M, a 34.2% increase year-over-year.
- ADC Therapeutics SA annual Net Income (Loss) Attributable to Parent for 2024 was -$158M, a 34.2% increase from 2023.
- ADC Therapeutics SA annual Net Income (Loss) Attributable to Parent for 2023 was -$240M, a 52.8% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)